RM 1 Local Health Unit

Rome, Italy

RM 1 Local Health Unit

Rome, Italy
SEARCH FILTERS
Time filter
Source Type

La Torre G.,University of Rome La Sapienza | Saulle R.,University of Rome La Sapienza | Unim B.,University of Rome La Sapienza | Meggiolaro A.,University of Rome La Sapienza | And 3 more authors.
Human Vaccines and Immunotherapeutics | Year: 2017

Objectives: To evaluate the effectiveness of the measles-mumps-rubella (MMR) vaccine in reducing hospitalizations for infectious disease, targeted and not targeted, as well as from respiratory diseases in children in Rome. Methods: The cohort was recomposed through record linkage of 2 archives (vaccination register and hospital discharge records. Results: The analysis included 11,004 children. 20.9% did not receive the MMR vaccination, 49% and 30.1% received one and 2 doses. There were no hospitalizations for rubella, 2 for mumps, and 12 for measles. The vaccine was highly protective against measles and mumps hospitalizations (HR = 0.10; 95% CI: 0.03.0.34). Regarding all infectious diseases there were 414 hospitalizations, and the vaccine was protective (HR = 0.29; 95% CI: 0.25 to 0.34). Concerning respiratory diseases, there were 809 admissions (7.4%), and the vaccine was highly protective (HR: 0.18; 95% CI: 0.07 to 0.48). Conclusions: MMR vaccination is effective for the primary prevention of target and not targeted infectious diseases and may also limit hospitalizations for respiratory diseases. © 2017 Taylor & Francis

Loading RM 1 Local Health Unit collaborators
Loading RM 1 Local Health Unit collaborators